Form 4: iRhythm Technologies Executive Chad Patterson Reports Acquisition of Restricted Stock Units

Chief Commercial Officer Chad Patterson of iRhythm Technologies reports the acquisition of 10,742 restricted stock units (RSUs) on February 28, 2024.

Summary

• Chad Patterson, Chief Commercial Officer of iRhythm Technologies, filed a Form 4 on March 1, 2024, reporting a transaction on February 28, 2024.
• Patterson acquired 10,742 restricted stock units (RSUs) at a price of $0.
• Following the transaction, Patterson beneficially owns 40,942 shares of common stock directly.
• The RSUs vest 25% on February 28, 2025, and annually thereafter, contingent upon continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of RSUs by a key executive suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of RSUs by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs incentivizes the Reporting Person to remain with the company.

Industry Context

Executive compensation in the form of stock options and RSUs is a common practice in the technology industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the tech and healthcare sectors, to incentivize executives and align their interests with shareholder value.
• Companies like Medtronic, Boston Scientific, and Abbott also utilize RSUs and stock options as part of their executive compensation packages.
• The vesting schedules and amounts of RSUs granted to executives vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The acquisition of RSUs by a key executive can positively influence shareholder sentiment.

Key Dates